LAUSR

Abscisic acid (ABA), a well‐known natural phytohormone reportedly exerts anti‐inflammatory and anti‐oxidative properties in diabetes and colitis. However, the efficacy of ABA against allergic airway inflammation and the underlying mechanism remain unknown. Herein, an OVA‐induced murine allergic airway inflammation model was established and treated with ABA in the presence or absence of PPAR‐γ antagonist GW9662. The results showed that ABA effectively stunted the development of airway inflammation, and concordantly downregulated OVA‐induced activation of NLRP3 inflammasome, suppressed oxidative stress and decreased the expression of mitochondrial fusion/fission markers including Optic Atrophy 1 (OPA1), Mitofusion 2 (Mfn2), dynamin‐related protein 1 (DRP1) and Fission 1 (Fis1). Moreover, ABA treatment further increased OVA‐induced expression of PPAR‐γ, while GW9662 abrogated the inhibitory effect of ABA on allergic airway inflammation as well as on the activation of NLRP3 inflammasome and oxidative stress. Consistently, ABA inhibited the activation of NLRP3 inflammasome, suppressed oxidative stress and mitochondrial fusion/fission in LPS‐stimulated Raw264.7 cells via PPAR‐γ. Collectively, ABA ameliorates OVA‐induced allergic airway inflammation in a PPAR‐γ dependent manner, and such effect of ABA may be associated with its inhibitory effect on NLRP3 inflammasome and oxidative stress. Our results suggest the potential of ABA or ABA‐rich food in protecting against asthma.